MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.47 -0.23 (-1.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Cash from Financing Activities (2021 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) recorded Cash from Financing Activities of $234.62 million in Q2 2026, up 665.6% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Cash from Financing Activities (2021 - 2026) Analysis & Trends

On a TTM basis, MoonLake Immunotherapeutics' Cash from Financing Activities came in at $338.14 million as of Jun 30, 2026, up 360.3% year-over-year; for FY2025, it was $146 million, up 184.5% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $51.31 million in FY2024 (-89.3%), $479.7 million in FY2023 (+300.8%), $119.69 million in FY2022 (+176.7%) and $43.26 million in FY2021 (-62.9%).
  • The Q2 2026 figure is the highest quarterly Cash from Financing Activities since Q2 2023.
  • On a year-over-year basis, Cash from Financing Activities rose in two of the last four quarters, with growth averaging 12.0%.
  • Per Business Quant, the preceding three quarters came in at $30.64 million (Q1 2026), $72.4 million (Q4 2025) and $480,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - 234.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 234.62 Mn
Mar 31, 2026 30.64 Mn
Dec 31, 2025 72.40 Mn
Sep 30, 2025 480,000.00
Mar 31, 2025 73.12 Mn
Dec 31, 2024 151,000.00
Sep 30, 2024 183,000.00
Mar 31, 2024 50.98 Mn
Dec 31, 2023 28.42 Mn
Jun 30, 2023 451.29 Mn
Dec 31, 2022 3,791.00
Jun 30, 2022 104.69 Mn
Mar 31, 2022 15.00 Mn
Dec 31, 2021 15.00 Mn
Sep 30, 2021 498,331.00
Jun 30, 2021 27.82 Mn
Mar 31, 2021 -58,063.00
API Access

MoonLake Immunotherapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MLTX&period=max&api_key=YOUR_API_KEY